Global Health Investment Corporation — Full Portfolio
32 tracked investments · listed companies and verified rows first
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Founder)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesDolby Family Ventures+6 more
Access Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases.
BiotechHealthtechMedical DevicesSomerset, US
Young Ho Choi(Executive Officer, Director)
BoardTom Sabourin(Director)Seung Jae Baek(Director)Sang Hoon Kang(Director)
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.
BiotechDeep TechHealthtechMedical Devices
Stuart Milstein(Chief Platform Officer, Co-founder)inJack O’Meara(Chief Executive Officer, Co-founder)inDave Hardwicke(Director, Head of Business Development, Co-founder)
Co-investorsage1BackedBlueYard CapitalEntrepreneur FirstIaso VenturesLingotto+6 more
Alydia Health manufactures the JADA System, an intrauterine device that uses low-level vacuum to control postpartum hemorrhage in hospital settings.
HealthtechMedical Devices
Co-investorsAstiaAvestria VenturesGlobal Health Investment Fund
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina Smolke(Founder)inKristy Hawkins(Founder)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
BoardRam Shriram(Director)
Co-investorsAmerica's Frontier FundCivilization Ventures Management, LlcIn-Q-TelLam CapitalSherpalo VenturesWestern Technology Investment
Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials.
AI & Machine LearningBiotechDeep TechHealthtech
Co-investorsFlagship Pioneering
Atomo Diagnostics develops diagnostic ecosystems and mobile applications for point-of-care testing, including whole-blood cassettes and reader devices compatible with smartphones for remote diagnostics.
BiotechDeep TechDigital HealthHealthtechMedical Devices
John Kelly(Founder and CEO)in
Co-investorsSydney AngelsTransition Level Investments
Biolinq develops glucose-sensing technology based on micro-array biosensors for metabolic health monitoring, including continuous glucose monitoring.
BiotechDigital HealthHardwareHealthtechMedical DevicesSan Diego, US
Jared Tangney(Co-founder)inRich Yang(Co-founder)inEdward Kliphuis(Director)
BoardDaniel Bradbury(Director)inLana Ghanem(Director)
Co-investorsAlpha Wave GlobalRiverVest Venture PartnersAble PartnersAphelion CapitalAverin CapitalBeyond Capital+7 more
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesAthosCivilization Ventures Management, LlcIn-Q-TelSherpalo VenturesViking Global Investors
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
BiotechHealthtech
Jacob Glanville(Founder)inStephanie Wisner(Founder)in
Co-investorsAbbhi CapitalAmplify PartnersBold Capital PartnersFuture VenturesKendall Capital PartnersNFX
Endpoint Health develops and commercializes precision therapeutics and therapy-guiding diagnostic tests targeted to each patient's biology, focused on immune-driven critical and chronic illnesses.
BiotechDigital HealthHealthtechSan Francisco, US
Diego Rey(Founder/CSO)inJeff Osborn(Founder)inJason Springs(Founder)inLeonardo Teixeira(Founder)in
Co-investorsAlix VenturesKnockout CapitalY CombinatorAME Cloud VenturesBoom CapitalBoom Capital Ventures+6 more
Genedrive Diagnostics develops and commercialises a rapid point-of-care pharmacogenetic testing platform that detects genetic variants to guide personalised medicine decisions in emergency healthcare.
BiotechDigital HealthMedical Devices
Gino Mielein
Co-investorsSeneca Partners
HealthtechReno, US
Tsontcho Ianchulev(Executive Officer, Director)Charles Warden(Director)Brian Walsh(Executive Officer, Director)Bruce J. Brumfield, Jr.(Director)Glenn Rockman(Director)inJim Mazzo(Director)
Co-investorsVisionary VenturesGlobal Health Investment Fund
Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
David Michael Salter(Executive Officer, Director)Mike Salter(CEO/President)inEugene Chen(Director)Keith Brown(Executive Officer, Director)Joel Rotroff(Director)
BoardCourt Turner(Director)
Co-investorsArboretum VenturesBaird CapitalLYZZ Capital
Micron Biomedical develops dissolvable microarray technology for vaccine and therapeutic delivery as an alternative to traditional injections, targeting expanded global access to treatments across all age groups.
BiotechHealthtechMedical DevicesAtlanta, US
Mark Prausnitz(Director)inHenry Sebastien(Executive Vice President, Head of Technical Operations)Devin McAllister(Executive Vice President, Chief Technology Officer)inIdean Marvasty(Chief Financial Officer)Steve Damon(Chief Executive Officer)in
BoardBas Van Buijtenen(Director)
Co-investorsGRA VentureJ2 VenturesGlobal Health Security
Monod Bio is a University of Washington spin-out that uses AI-powered de novo protein design to develop research-use-only tools and in vitro diagnostics.
AI & Machine LearningBiotechMedical DevicesSeattle, US
Daniel Adriano Silva Manzano(Executive Officer, Director)Alfredo Quijano Rubio(Co-Founder, CSO, Board Observer)inDaniel Silva Manzano(Co-Founder, CEO, Board Member)Greg Tibbitts(Fractional CFO)Dave Johnson(Director)David Shoultz(Executive Officer, Director)
Co-investorsPack Ventures
PHC Global builds AI-driven systems that fuse distributed biological data streams (wastewater, clinical, syndromic, environmental) with contextual intelligence to detect anomalies and produce decision-ready biological threat intelligence.
AI & Machine LearningDefense TechHealthtech
Charity Dean(Founder)
Co-investorsVenrock
Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsPACE Healthcare Capital
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)William S. Marth, RPh., MBA(President & CEO)
BoardRobert Nelsen(Chairman, Resilience; Founder, ARCH)
Co-investors8VCARCH Venture PartnersCatalio Capital Management, LPGV (Google Ventures)JIMCOKoch Disruptive Technologies+16 more
Serum Institute of India (SII) develops and manufactures vaccines, including candidates for tuberculosis and Bundibugyo ebolavirus, working with partners such as the Oxford Vaccine Group and the Gates Medical Research Institute.
BiotechHealthtech
Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections.
BiotechDeep TechMedical Devices
Rachel Sha(CEO)in
Co-investorsRA CapitalThe Engine VenturesUlu Ventures
Biomanufacturing technology platform and CDMO (Global Health Investment Fund & Global Health Security Fund)
Co-investorsAdBio partnersIn-Q-TelInnovation Fund sa/nvInventures Investment Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BDBugSeq BioinformaticsEUBiologicsMoxidectinPATHThemis BioscienceTransform Health FundVaxess Technologies, Inc.Verge HealthTechWomen's and Children's Health Technology Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





















































































